OtherBASIC SCIENCE INVESTIGATIONS
microPET of Tumor Integrin αvβ3 Expression Using 18F-Labeled PEGylated Tetrameric RGD Peptide (18F-FPRGD4)
Zhanhong Wu, Zi-Bo Li, Kai Chen, Weibo Cai, Lina He, Frederick T. Chin, Fang Li and Xiaoyuan Chen
Journal of Nuclear Medicine September 2007, 48 (9) 1536-1544; DOI: https://doi.org/10.2967/jnumed.107.040816
Zhanhong Wu
Zi-Bo Li
Kai Chen
Weibo Cai
Lina He
Frederick T. Chin
Fang Li
In this issue
Journal of Nuclear Medicine
Vol. 48, Issue 9
September 2007
microPET of Tumor Integrin αvβ3 Expression Using 18F-Labeled PEGylated Tetrameric RGD Peptide (18F-FPRGD4)
Zhanhong Wu, Zi-Bo Li, Kai Chen, Weibo Cai, Lina He, Frederick T. Chin, Fang Li, Xiaoyuan Chen
Journal of Nuclear Medicine Sep 2007, 48 (9) 1536-1544; DOI: 10.2967/jnumed.107.040816
Jump to section
Related Articles
Cited By...
- Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer
- In Vivo Characterization of 4 68Ga-Labeled Multimeric RGD Peptides to Image {alpha}v{beta}3 Integrin Expression in 2 Human Tumor Xenograft Mouse Models
- Multicenter Reproducibility of 18F-Fluciclatide PET Imaging in Subjects with Solid Tumors
- 18F-Alfatide II and 18F-FDG Dual-Tracer Dynamic PET for Parametric, Early Prediction of Tumor Response to Therapy
- Radiopeptide Imaging and Therapy in the United States
- 18F-FPPRGD2 and 18F-FDG PET of Response to Abraxane Therapy
- PET Imaging of Tumor Neovascularization in a Transgenic Mouse Model with a Novel 64Cu-DOTA-Knottin Peptide
- 111In-LLP2A-DOTA Polyethylene Glycol-Targeting {alpha}4{beta}1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies
- Multimodality Molecular Imaging of Tumor Angiogenesis
- 18F-Labeled BBN-RGD Heterodimer for Prostate Cancer Imaging